当前位置：
X-MOL 学术
›
Mol. Neurodegener.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Erratum to: Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression.
Molecular Neurodegeneration ( IF 14.9 ) Pub Date : 2015-10-27 , DOI: 10.1186/s13024-015-0051-6 Xi Chen 1, 2 , Hannah V McCue 1 , Shi Quan Wong 1 , Sudhanva S Kashyap 1 , Brian C Kraemer 3 , Jeff W Barclay 1 , Robert D Burgoyne 1 , Alan Morgan 1
Molecular Neurodegeneration ( IF 14.9 ) Pub Date : 2015-10-27 , DOI: 10.1186/s13024-015-0051-6 Xi Chen 1, 2 , Hannah V McCue 1 , Shi Quan Wong 1 , Sudhanva S Kashyap 1 , Brian C Kraemer 3 , Jeff W Barclay 1 , Robert D Burgoyne 1 , Alan Morgan 1
Affiliation
The original version of this article [1] unfortunately contained a mistake. The author list contained a spelling error for the author Hannah V. McCue. The original article has been corrected for this error. The corrected author list is given below:Xi Chen, Hannah V. McCue, Shi Quan Wong, Sudhanva S. Kashyap, Brian C. Kraemer, Jeff W. Barclay, Robert D. Burgoyne and Alan Morgan
中文翻译：
勘误如下：乙草胺通过调节DAF-16 / FOXO靶基因表达来改善神经退行性疾病的表型。
不幸的是，本文的原始版本[1]包含一个错误。作者列表包含作者Hannah V. McCue的拼写错误。原始文章已得到纠正此错误。更正后的作者列表如下：Xi Chen，Hannah V. McCue，Shi Quan Wong，Sudhanva S. Kashyap，Brian C. Kraemer，Jeff W. Barclay，Robert D. Burgoyne和Alan Morgan
更新日期：2019-11-01
中文翻译：
勘误如下：乙草胺通过调节DAF-16 / FOXO靶基因表达来改善神经退行性疾病的表型。
不幸的是，本文的原始版本[1]包含一个错误。作者列表包含作者Hannah V. McCue的拼写错误。原始文章已得到纠正此错误。更正后的作者列表如下：Xi Chen，Hannah V. McCue，Shi Quan Wong，Sudhanva S. Kashyap，Brian C. Kraemer，Jeff W. Barclay，Robert D. Burgoyne和Alan Morgan
京公网安备 11010802027423号